Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia

Biochemical Pharmacology

Volumn 86, Issue 7, 2013, Pages 970-978

  Riahi, Golnasim ^a,b,c   Morissette, Marc ^b   Samadi, Pershia ^a,b   Parent, Martin ^a,c   Di Paolo, Thérèse ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

Author keywords

Basal ganglia; MPTP; Neurodegenerative disorders; Parkinson's disease; Primate; Serotonin receptor 1B

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIMETHOXY N [4 (3 NITROPHENYL) 2 THIAZOLYL]BENZENESULFONAMIDE; ANTIPARKINSON AGENT; BENSERAZIDE PLUS LEVODOPA; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 3 METHYL 4 (4 PYRIDYL)BENZAMIDE; SEROTONIN 1B RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BASAL GANGLION; CAUDATE NUCLEUS; CONTROLLED STUDY; DRUG INDUCED DISEASE; DYSKINESIA; FEMALE; GLOBUS PALLIDUS; HAPLORHINI; LONG TERM CARE; NONHUMAN; NUCLEUS ACCUMBENS; OSMOTIC MINIPUMP; PARKINSONISM; PRIORITY JOURNAL; PUTAMEN; RECEPTOR BINDING; SUBSTANTIA INNOMINATA; SUBSTANTIA NIGRA PARS RETICULATA;

5-HIAA; 5-HT; 5-HYDROXYINDOLEACETIC ACID; 5-HYDROXYTRYPTAMINE (SEROTONIN); 6-HYDROXYDOPAMINE; 6-OHDA; AC; ANTERIOR COMMISSURE; BASAL GANGLIA; GABA; GAD; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID DECARBOXYLASE; L-3,4-DIHYDROXYPHENYLALANINE; L-DOPA; L-DOPA-INDUCED DYSKINESIA; LID; MPTP; NEURODEGENERATIVE DISORDERS; PARKINSON'S DISEASE; PD; PRIMATE; SEROTONIN RECEPTOR 1B;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; AUTORADIOGRAPHY; BASAL GANGLIA; BEHAVIOR, ANIMAL; BENZAMIDES; BRAIN; CASE-CONTROL STUDIES; DYSKINESIA, DRUG-INDUCED; LEVODOPA; MACACA FASCICULARIS; PARKINSON DISEASE; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1B; SEROTONIN; SULFONAMIDES; THIAZOLES;

EID: 84884670652     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.08.005     Document Type: Article

References (48)

1. C.W. Olanow, R.L. Watts, and W.C. Koller An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines Neurology 56 2001 S1 S88
2. S.H. Fox, R. Chuang, and J.M. Brotchie Serotonin and Parkinson's disease: on movement, mood, and madness Mov Disord 24 2009 1255 1266
3. P. Samadi, L. Grégoire, M. Morissette, F. Calon, A. Hadj Tahar, and M. Dridi mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys Neurobiol Aging 29 2008 1040 1051 (Pubitemid 351697993)
4. P. Samadi, M. Morissette, F. Calon, A. Hadj Tahar, M. Dridi, and N. Bélanger Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L-DOPA-induced dyskinesias in MPTP parkinsonian monkeys Synapse 62 2008 101 109
5. M. Carta, T. Carlsson, D. Kirik, and A. Bjorklund Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats Brain 130 2007 1819 1833 (Pubitemid 47343795)
6. K. Varnas, Y.L. Hurd, and H. Hall Regional expression of 5-HT1B receptor mRNA in the human brain Synapse 56 2005 21 28 (Pubitemid 40322360)
7. M.E. Castro, J. Pascual, T. Romon, J. Berciano, J. Figols, and A. Pazos 5-HT1B receptor binding in degenerative movement disorders Brain Res 790 1998 323 328 (Pubitemid 28234519)
8. 11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain Neuroimage 41 2008 1075 1085
9. R. Bouhelal, L. Smounya, and J. Bockaert 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra Eur J Pharmacol 151 1988 189 196
10. G. Engel, M. Gothert, D. Hoyer, E. Schlicker, and K. Hillenbrand Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites Naunyn Schmiedebergs Arch Pharmacol 332 1986 1 7 (Pubitemid 16149704)
11. 3H]5-HT release in raphe, frontal cortex and hippocampus of 5-HT1B knock-out mice Neuroreport 7 1995 353 359
12. N.M. Barnes, and T. Sharp A review of central 5-HT receptors and their function Neuropharmacology 38 1999 1083 1152 (Pubitemid 29292403)
13. U. Boschert, D.A. Amara, L. Segu, and R. Hen The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals Neuroscience 58 1994 167 182
14. A. Ghavami, K.L. Stark, M. Jareb, S. Ramboz, L. Segu, and R. Hen Differential addressing of 5-HT1A and 5-HT1B receptors in epithelial cells and neurons J Cell Sci 112 Pt 6 1999 967 976 (Pubitemid 29179329)
15. S.W. Johnson, N.B. Mercuri, and R.A. North 5-hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons J Neurosci 12 1992 2000 2006
16. H. Morikawa, O.J. Manzoni, J.C. Crabbe, and J.T. Williams Regulation of central synaptic transmission by 5-HT(1B) auto- and heteroreceptors Mol Pharmacol 58 2000 1271 1278
17. P. Calabresi, M. Di Filippo, V. Ghiglieri, and B. Picconi Molecular mechanisms underlying levodopa-induced dyskinesia Mov Disord 23 Suppl 3 2008 S570 S579
18. K.B. Dupre, C.Y. Ostock, K.L. Eskow Jaunarajs, T. Button, L.M. Savage, and W. Wolf Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats Exp Neurol 229 2011 288 299
19. C.Y. Ostock, K.B. Dupre, K.L. Jaunarajs, H. Walters, J. George, and D. Krolewski Role of the primary motor cortex in L-DOPA-induced dyskinesia and its modulation by 5-HT1A receptor stimulation Neuropharmacology 61 2011 753 760
20. A. Munoz, Q. Li, F. Gardoni, E. Marcello, C. Qin, and T. Carlsson Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia Brain 131 2008 3380 3394
21. K.L. Jaunarajs, K.B. Dupre, A. Steiniger, A. Klioueva, A. Moore, and C. Kelly Serotonin 1B receptor stimulation reduces D1 receptor agonist-induced dyskinesia Neuroreport 20 2009 1265 1269
22. X. Zhang, P.E. Andren, P. Greengard, and P. Svenningsson Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in L-DOPA treatment of an animal model of Parkinsonism Proc Natl Acad Sci USA 105 2008 2163 2168 (Pubitemid 351439482)
23. L. Grégoire, A. Rassoulpour, P. Guidetti, P. Samadi, P.J. Bédard, and E. Izzo Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys Behav Brain Res 186 2008 161 167 (Pubitemid 350122751)
24. R.F. Martin, and D.M. Bowden Primate brain maps: structure of the macaque brain 2000 Elsevier Science Amsterdam, The Netherlands
25. G. Riahi, M. Morissette, D. Levesque, C. Rouillard, P. Samadi, and M. Parent Effect of chronic L-DOPA treatment on 5-HT(1A) receptors in parkinsonian monkey brain Neurochem Int 61 2012 1160 1171
26. M.K. Tamim, P. Samadi, M. Morissette, L. Gregoire, B. Ouattara, and D. Levesque Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides Neuropharmacology 58 2010 286 296
27. G.L. Alberts, J.F. Pregenzer, W.B. Im, and J.L. Slightom Cloning of serotonin 5-HT(1) receptor subtypes from the chimpanzee, gorilla and Rhesus monkey and their agonist-induced guanosine 5′gamma(35)S triphosphate binding Neurosci Lett 280 2000 223 227 (Pubitemid 30089841)
28. H. Jin, D. Oksenberg, A. Ashkenazi, S.J. Peroutka, A.M. Duncan, and R. Rozmahel Characterization of the human 5-hydroxytryptamine1B receptor J Biol Chem 267 1992 5735 5738
29. D. Oksenberg, S.A. Marsters, B.F. O'Dowd, H. Jin, S. Havlik, and S.J. Peroutka A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors Nature 360 1992 161 163
30. R.B. McCall, R. Huff, C.L. Chio, R. TenBrink, C.L. Bergh, and M.D. Ennis Preclinical studies characterizing the anti-migraine and cardiovascular effects of the selective 5-HT1D receptor agonist PNU-142633 Cephalalgia 22 2002 799 806 (Pubitemid 36609322)
31. D. Frechilla, A. Cobreros, L. Saldise, R. Moratalla, R. Insausti, and M. Luquin Serotonin 5-HT(1A) receptor expression is selectively enhanced in the striosomal compartment of chronic parkinsonian monkeys Synapse 39 2001 288 296 (Pubitemid 32128650)
32. I. Perez-Otano, M.T. Herrero, C. Oset, M.L. De Ceballos, M.R. Luquin, and J.A. Obeso Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmoset Brain Res 567 1991 127 132
33. G. Riahi, M. Morissette, M. Parent, and T. Di Paolo Brain 5-HT(2A) receptors in MPTP monkeys and levodopa-induced dyskinesias Eur J Neurosci 33 2011 1823 1831
34. S.J. Kish, J. Tong, O. Hornykiewicz, A. Rajput, L.J. Chang, and M. Guttman Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease Brain 131 2008 120 131
35. P. Huot, T.H. Johnston, L. Winkelmolen, S.H. Fox, and J.M. Brotchie 5-HT2A receptor levels increase in MPTP-lesioned macaques treated chronically with L-DOPA Neurobiol Aging 33 2012 194 e5 e19400015
36. C. Pifl, G. Schingnitz, and O. Hornykiewicz Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey Neuroscience 44 1991 591 605
37. C. Davidson, and J.A. Stamford Evidence that 5-hydroxytryptamine release in rat dorsal raphe nucleus is controlled by 5-HT1A, 5-HT1B and 5-HT1D autoreceptors Br J Pharmacol 114 1995 1107 1109
38. M. Muramatsu, M.D. Lapiz, E. Tanaka, and J. Grenhoff Serotonin inhibits synaptic glutamate currents in rat nucleus accumbens neurons via presynaptic 5-HT1B receptors Eur J Neurosci 10 1998 2371 2379
39. V.A. Bouryi, and D.I. Lewis The modulation by 5-HT of glutamatergic inputs from the raphe pallidus to rat hypoglossal motoneurones, in vitro J Physiol 553 2003 1019 1031 (Pubitemid 38035641)
40. J.C. Lemos, Y.Z. Pan, X. Ma, C. Lamy, A.C. Akanwa, and S.G. Beck Selective 5-HT receptor inhibition of glutamatergic and GABAergic synaptic activity in the rat dorsal and median raphe Eur J Neurosci 24 2006 3415 3430 (Pubitemid 44952608)
41. P. Greengard The neurobiology of slow synaptic transmission Science 294 2001 1024 1030 (Pubitemid 33041850)
42. J. Aceves, B. Floran, D. Martinez-Fong, J. Benitez, A. Sierra, and G. Flores Activation of D1 receptors stimulates accumulation of gamma-aminobutyric acid in slices of the pars reticulata of 6-hydroxydopamine-lesioned rats Neurosci Lett 145 1992 40 42
43. M. Ochi, S. Shiozaki, and H. Kase L-DOPA-induced modulation of GABA and glutamate release in substantia nigra pars reticulata in a rodent model of Parkinson's disease Synapse 52 2004 163 165 (Pubitemid 38429044)
44. N. Yamamoto, R.C. Pierce, and J.J. Soghomonian Subchronic administration of L-DOPA to adult rats with a unilateral 6-hydroxydopamine lesion of dopamine neurons results in a sensitization of enhanced GABA release in the substantia nigra, pars reticulata Brain Res 1123 2006 196 200
45. S.J. Kish, A. Rajput, J. Gilbert, B. Rozdilsky, L.J. Chang, and K. Shannak Elevated gamma-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: correlation with striatal dopamine loss Ann Neurol 20 1986 26 31 (Pubitemid 16063232)
46. A.R. Carta, S. Fenu, P. Pala, E. Tronci, and M. Morelli Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats Eur J Neurosci 18 2003 2563 2572 (Pubitemid 37452672)
47. M.A. Cenci, C.S. Lee, and A. Bjorklund L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA Eur J Neurosci 10 1998 2694 2706 (Pubitemid 28362576)
48. I.M. Stanford, and M.G. Lacey Differential actions of serotonin, mediated by 5-HT1B and 5-HT2C receptors, on GABA-mediated synaptic input to rat substantia nigra pars reticulata neurons in vitro J Neurosci 16 1996 7566 7573 (Pubitemid 26389696)